Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
957 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05254171 | Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer(ASPIRE) | recruiting | Phase 2 / Phase 3 | 600 | Panbela Therapeutics, Inc.INDUSTRY | 10 | Nov 6, 2024 | clinicaltrials |
| NCT06097533 | Improvement of Quality of Life by Cannabinoids in Oncologic Patients(BELCANTO) | recruiting | Phase 2 | 170 | University Hospital Schleswig-HolsteinOTHER | 1 | Oct 26, 2024 |
| clinicaltrials |
| NCT04289935 | Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer(VISION I) | recruiting | N/A | 420 | Klinik Hirslanden, ZurichOTHER | 4 | Oct 23, 2024 | clinicaltrials |
| NCT06621277 | JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors(JUMP_START) | recruiting | — | 250 | University Hospital HeidelbergOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06642831 | Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study(PHOEBE) | recruiting | — | 380 | University Hospital ErlangenOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06626386 | Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)(PSA-Cap) | recruiting | — | 200 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT05773651 | Rare Tumours in Children and Adolescents (STEP)(STEP 2 0) | recruiting | — | 10,000 | University Hospital TuebingenOTHER | 1 | Oct 1, 2024 | clinicaltrials |
| NCT06621810 | Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults(AI-MEL) | recruiting | — | 3,000 | German Cancer Research CenterOTHER | 3 | Oct 1, 2024 | clinicaltrials |
| NCT06214611 | Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors(ART in HNT) | recruiting | N/A | 50 | University Hospital, EssenOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06216171 | Adaptive Radiotherapy in Head and Neck Tumor Patients(ProHEART) | recruiting | N/A | 30 | University Hospital, EssenOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06247163 | PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.(PET-ART) | recruiting | — | 30 | University Hospital, EssenOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06253338 | Optimization of Radiation Protection Through Genomic Analyses(ORtogether) | recruiting | N/A | 30 | University Hospital, EssenOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06137378 | European Larynx Organ Preservation Study (ELOS) [MK-3475-C44](ELOS) | recruiting | Phase 2 | 140 | University of LeipzigOTHER | 1 | Sep 20, 2024 | clinicaltrials |
| NCT05153694 | Infectious Complications After Cystectomy: A Prospective Observational Study | recruiting | — | 200 | Ludwig-Maximilians - University of MunichOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT04498767 | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)(OligoRARE) | recruiting | N/A | 200 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Aug 26, 2024 | clinicaltrials |
| NCT04838652 | Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma(Pembro-CORE) | recruiting | Phase 2 | 29 | University of CologneOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT02131753 | Therapy Optimisation for the Treatment of Hairy Cell Leukemia | recruiting | Phase 2 / Phase 3 | 210 | University of GiessenOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT03488953 | Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver Metastases(LIVERT(W)OHEAL) | recruiting | N/A | 40 | Jena University HospitalOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT03676504 | Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR | recruiting | Phase 1 / Phase 2 | 68 | University Hospital HeidelbergOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06526065 | Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict) | recruiting | — | 500 | University Medical Center GoettingenOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT04837859 | Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma(INDIE) | recruiting | Phase 2 | 120 | University of CologneOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT03222635 | Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma(PREFER) | recruiting | N/A | 225 | Amsterdam UMCOTHER | 6 | Jul 24, 2024 | clinicaltrials |
| NCT05844046 | Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients(MONTBLANC) | recruiting | Phase 2 | 83 | Enrico De ToniOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT06243393 | Sacituzumab Govitecan in Metastatic Colorectal Cancer(TROPHIT1) | recruiting | Phase 2 / Phase 3 | 80 | University Hospital HeidelbergOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT06482684 | CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma(CARMAN) | recruiting | Phase 2 | 150 | Christian Schmidt, MDOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT04678583 | Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer(ARMANI) | recruiting | N/A | 240 | Technische Universität DresdenOTHER | 1 | Jun 13, 2024 | clinicaltrials |
| NCT04865250 | Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC(iReP) | recruiting | Phase 2 | 20 | University Hospital HeidelbergOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05646550 | Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer(ProSperACC-1) | recruiting | Phase 1 | 56 | University Hospital TuebingenOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06019130 | Nivolumab in Children and Adults With Nasopharyngeal Carcinoma(NPC-Nivo) | recruiting | Phase 2 | 57 | German Society for Pediatric Oncology and Hematology GPOH gGmbHOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05397262 | Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia(HyBla_RCT) | recruiting | N/A | 1,000 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT05502887 | The Endothelial Cell Dysfunction and Outcome Project for Hematological Neoplasms(EndoCDO-H) | recruiting | — | 1,000 | Prof. Dr. Thomas LuftOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)(BoB) | recruiting | Phase 2 | 1,000 | Vall d'Hebron Institute of OncologyOTHER | 7 | Apr 25, 2024 | clinicaltrials |
| NCT03659448 | Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer | recruiting | Phase 3 | 300 | SurgimabINDUSTRY | 4 | Apr 24, 2024 | clinicaltrials |
| NCT06169956 | An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany(NENI) | recruiting | — | 400 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 18, 2024 | clinicaltrials |
| NCT04793919 | Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia | recruiting | Phase 2 | 89 | Associazione Italiana Ematologia Oncologia PediatricaOTHER | 12 | Apr 15, 2024 | clinicaltrials |
| NCT05791409 | Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL(AETHER) | recruiting | Phase 1 / Phase 2 | 112 | Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER | 4 | Apr 12, 2024 | clinicaltrials |
| NCT04128072 | Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma(MOGAT) | recruiting | Phase 2 | 43 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Apr 5, 2024 | clinicaltrials |
| NCT06223711 | Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC | recruiting | Phase 2 | 43 | Universität des SaarlandesOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT06330909 | Image-guided Focal Dose Escalation- Primary pc Treated With Primary External Beam Hypofract.Stereotactic rt(HypoF-SBRT) | recruiting | N/A | 374 | University Hospital FreiburgOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT06320223 | PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer(PROMISE-PET) | recruiting | — | 10,000 | University Hospital, EssenOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT05280314 | Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors | recruiting | Phase 2 | 60 | IO BiotechINDUSTRY | 6 | Mar 18, 2024 | clinicaltrials |
| NCT04455282 | CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1(CIRCULATE1) | recruiting | — | 100 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT00330447 | Effects of Oncological Treatment During Pregnancy on Mother and Child | recruiting | — | 5,000 | University Hospital, GasthuisbergOTHER | 20 | Mar 6, 2024 | clinicaltrials |
| NCT06283927 | The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)(RECSUR) | recruiting | — | 464 | Jasper GerritsenOTHER | 5 | Feb 28, 2024 | clinicaltrials |
| NCT06118723 | The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)(SUPRAMAX) | recruiting | — | 784 | Jasper GerritsenOTHER | 5 | Feb 22, 2024 | clinicaltrials |
| NCT06273176 | The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma(RECMAP) | recruiting | — | 225 | Erasmus Medical CenterOTHER | 5 | Feb 22, 2024 | clinicaltrials |
| NCT06266026 | ThermoBreast - Non-contact Breast Cancer Imaging Using AI-enhanced Thermography.(ThermoBreast) | recruiting | N/A | 28,000 | ThermoMind Ltd.INDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT05007132 | Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer | recruiting | Phase 2 | 153 | Dominik Paul ModestOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT03222895 | Distribution of Lymph Node Metastases in Esophageal Carcinoma(TIGER) | recruiting | — | 5,000 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 14 | Feb 13, 2024 | clinicaltrials |
| NCT06230549 | Adaptive Radiotherapy in Patients With Gynecological Tumors(ProART) | recruiting | N/A | 30 | University Hospital, EssenOTHER | 1 | Feb 9, 2024 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials